LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
Gyroscope Therapeutics, a gene therapy company, has filed for an IPO. The number of shares and pricing terms have yet to be set. The stock will list on the NASDAQ under the ticker symbol “VISN.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback